{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:24:25Z","timestamp":1783175065466,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,14]]},"DOI":"10.7759\/cureus.45246","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:24:59Z","timestamp":1694712299000},"source":"Crossref","is-referenced-by-count":3,"title":["Hyperuricemia and Its Association With the Severity and Complications of Congestive Heart Failure: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Vijay P","family":"SN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo  P","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Yasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Singareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhini","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuheen Sankar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese G","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017, 3:7-11. 10.15420\/cfr.2016:25:2","journal-title":"Card Fail Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.8444","article-title":"Association of changing hospital readmission rates with mortality rates after hospital discharge","volume":"318","author":"Dharmarajan K","year":"2017","unstructured":"Dharmarajan K, Wang Y, Lin Z, et al.. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. 2017, 318:270-8. 10.1001\/jama.2017.8444","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and Stroke Statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao CW","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al.. Heart disease and Stroke Statistics-2022 update: a report from the American Heart Association. Circulation. 2022, 145:e153-639. 10.1161\/CIR.0000000000001052","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2777","article-title":"Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction, heart failure, and pneumonia","volume":"1","author":"Khera R","year":"2018","unstructured":"Khera R, Dharmarajan K, Wang Y, et al.. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction, heart failure, and pneumonia. JAMA Netw Open. 2018, 1:e182777. 10.1001\/jamanetworkopen.2018.2777","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.026","article-title":"Readmission and mortality after hospitalization for myocardial infarction and heart failure","volume":"75","author":"Ko DT","year":"2020","unstructured":"Ko DT, Khera R, Lau G, et al.. Readmission and mortality after hospitalization for myocardial infarction and heart failure. J Am Coll Cardiol. 2020, 75:736-46. 10.1016\/j.jacc.2019.12.026","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.09.006","article-title":"Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls","volume":"15","author":"Lesman-Leegte I","year":"2009","unstructured":"Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. J Card Fail. 2009, 15:17-23. 10.1016\/j.cardfail.2008.09.006","journal-title":"J Card Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-9842(00)00141-0","article-title":"More 'malignant' than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart S","year":"2001","unstructured":"Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001, 3:315-22. 10.1016\/s1388-9842(00)00141-0","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.08.015","article-title":"Uric acid is a biomarker of oxidative stress in the failing heart: lessons learned from trials with allopurinol and SGLT2 inhibitors","volume":"26","author":"Packer M","year":"2020","unstructured":"Packer M. Uric acid is a biomarker of oxidative stress in the failing heart: lessons learned from trials with allopurinol and SGLT2 inhibitors. J Card Fail. 2020, 26:977-84. 10.1016\/j.cardfail.2020.08.015","journal-title":"J Card Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.332.11779","article-title":"Serum uric acid level in the severity of congestive heart failure (CHF)","volume":"33","author":"Khan A","year":"2017","unstructured":"Khan A, Shah MH, Khan S, Shamim U, Arshad S. Serum uric acid level in the severity of congestive heart failure (CHF). Pak J Med Sci. 2017, 33:330-4. 10.12669\/pjms.332.11779","journal-title":"Pak J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2011.00200.x","article-title":"Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis","volume":"17","author":"Tamariz L","year":"2011","unstructured":"Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail. 2011, 17:25-30. 10.1111\/j.1751-7133.2011.00200.x","journal-title":"Congest Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389%2Ffmed.2021.785327","article-title":"Serum uric acid and risk of chronic heart failure: a systematic review and meta-analysis","volume":"8","author":"Miao L","year":"2021","unstructured":"Miao L, Guo M, Pan D, et al.. Serum uric acid and risk of chronic heart failure: a systematic review and meta-analysis. Front Med. 2021, 8:785327. 10.3389%2Ffmed.2021.785327","journal-title":"Front Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang H","year":"2014","unstructured":"Huang H, Huang B, Li Y, et al.. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014, 16:15-24. 10.1093\/eurjhf\/hft132","journal-title":"Eur J Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.16-192","article-title":"Hyperuricemia and atrial fibrillation","volume":"57","author":"Maharani N","year":"2016","unstructured":"Maharani N, Kuwabara M, Hisatome I. Hyperuricemia and atrial fibrillation. Int Heart J. 2016, 57:395-9. 10.1536\/ihj.16-192","journal-title":"Int Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000041431.57222.af","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser U","year":"2002","unstructured":"Landmesser U, Spiekermann S, Dikalov S, et al.. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002, 106:3073-8. 10.1161\/01.cir.0000041431.57222.af","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker SD","year":"2003","unstructured":"Anker SD, Doehner W, Rauchhaus M, et al.. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003, 107:1991-7. 10.1161\/01.CIR.0000065637.10517.A0","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","article-title":"Hyperuricemia and incident heart failure","volume":"2","author":"Krishnan E","year":"2009","unstructured":"Krishnan E. Hyperuricemia and incident heart failure. Circ Heart Fail. 2009, 2:556-62. 10.1161\/CIRCHEARTFAILURE.108.797662","journal-title":"Circ Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino K","year":"2010","unstructured":"Ogino K, Kato M, Furuse Y, et al.. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail. 2010, 3:73-81. 10.1161\/CIRCHEARTFAILURE.109.868604","journal-title":"Circ Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22083","article-title":"Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?","volume":"36","author":"Eisen A","year":"2013","unstructured":"Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?. Clin Cardiol. 2013, 36:110-6. 10.1002\/clc.22083","journal-title":"Clin Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2011.00259.x","article-title":"Hyperuricemia and the echocardiographic measures of myocardial dysfunction","volume":"18","author":"Krishnan E","year":"2012","unstructured":"Krishnan E, Hariri A, Dabbous O, Pandya BJ. Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail. 2012, 18:138-43. 10.1111\/j.1751-7133.2011.00259.x","journal-title":"Congest Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002092","article-title":"Uric acid in advanced heart failure: relation to central haemodynamics and outcome","volume":"9","author":"Deis T","year":"2022","unstructured":"Deis T, Rossing K, Ersb\u00f8ll MK, Wolsk E, Gustafsson F. Uric acid in advanced heart failure: relation to central haemodynamics and outcome. Open Heart. 2022, 9:e002092. 10.1136\/openhrt-2022-002092","journal-title":"Open Heart"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.09.001","article-title":"Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients","volume":"9","author":"Pascual-Figal DA","year":"2007","unstructured":"Pascual-Figal DA, Hurtado-Mart\u00ednez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail. 2007, 9:518-24. 10.1016\/j.ejheart.2006.09.001","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13210","article-title":"Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension","volume":"20","author":"Gu J","year":"2018","unstructured":"Gu J, Fan YQ, Zhang HL, Zhang JF, Wang CQ. Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension. J Clin Hypertens (Greenwich). 2018, 20:560-7. 10.1111\/jch.13210","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.11.083","article-title":"Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study","volume":"252","author":"Wannamethee SG","year":"2018","unstructured":"Wannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study. Int J Cardiol. 2018, 252:187-92. 10.1016\/j.ijcard.2017.11.083","journal-title":"Int J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.01.010","article-title":"Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study","volume":"142","author":"Ekundayo OJ","year":"2010","unstructured":"Ekundayo OJ, Dell'Italia LJ, Sanders PW, et al.. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol. 2010, 142:279-87. 10.1016\/j.ijcard.2009.01.010","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.04.013","article-title":"The prognostic impact of uric acid in patients with severely decompensated acute heart failure","volume":"68","author":"Okazaki H","year":"2016","unstructured":"Okazaki H, Shirakabe A, Kobayashi N, et al.. The prognostic impact of uric acid in patients with severely decompensated acute heart failure. J Cardiol. 2016, 68:384-91. 10.1016\/j.jjcc.2016.04.013","journal-title":"J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2018.08.008","article-title":"Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure","volume":"73","author":"Joho S","year":"2019","unstructured":"Joho S, Ushijima R, Nakagaito M, Kinugawa K. Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure. J Cardiol. 2019, 73:233-9. 10.1016\/j.jjcc.2018.08.008","journal-title":"J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.17-560","article-title":"Randomized trial of effect of urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia (LEAF-CHF)","volume":"59","author":"Yokota T","year":"2018","unstructured":"Yokota T, Fukushima A, Kinugawa S, Okumura T, Murohara T, Tsutsui H. Randomized trial of effect of urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia (LEAF-CHF). Int Heart J. 2018, 59:976-82. 10.1536\/ihj.17-560","journal-title":"Int Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in Hyperuricemic heart failure patients: the xanthine oxidase inhibition for Hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz MM","year":"2015","unstructured":"Givertz MM, Anstrom KJ, Redfield MM, et al.. Effects of xanthine oxidase inhibition in Hyperuricemic heart failure patients: the xanthine oxidase inhibition for Hyperuricemic heart failure patients (EXACT-HF) study. Circulation. 2015, 131:1763-71. 10.1161\/CIRCULATIONAHA.114.014536","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014525","article-title":"Prognostic value of serum uric acid in patients with acute heart failure: a meta-analysis","volume":"98","author":"Huang G","year":"2019","unstructured":"Huang G, Qin J, Deng X, et al.. Prognostic value of serum uric acid in patients with acute heart failure: a meta-analysis. Medicine (Baltimore). 2019, 98:e14525. 10.1097\/MD.0000000000014525","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179232-hyperuricemia-and-its-association-with-the-severity-and-complications-of-congestive-heart-failure-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:47Z","timestamp":1707509087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179232-hyperuricemia-and-its-association-with-the-severity-and-complications-of-congestive-heart-failure-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.45246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}